Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke

Stroke represents the second leading cause of mortality and morbidity worldwide. Ischemic strokes are the most prevalent type of stroke, and they are characterized by a series of pathological events prompted by an arterial occlusion that leads to a heterogeneous pathophysiological response through d...

Full description

Bibliographic Details
Main Author: Bernardo-Castro, S (author)
Other Authors: Albino, I (author), Barrera-Sandoval, ÁM (author), Tomatis, F (author), Sousa, JA (author), Martins, E (author), Simões, S (author), Lino, MM (author), Ferreira, L (author), Sargento-Freitas, J (author)
Format: article
Language:eng
Published: 2022
Subjects:
AVC Isquémico
Nanopartículas
Ischemic Stroke
Nanoparticles
Online Access:http://hdl.handle.net/10400.4/2335
Country:Portugal
Oai:oai:rihuc.huc.min-saude.pt:10400.4/2335

Internet

http://hdl.handle.net/10400.4/2335

Similar Items